CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients.

Ruiz, P; Weppler, D; Tryphonopoulos, P; Nishida, S; Moon, J; Kato, T; Selvaggi, G; Levi, D; Madariaga, J; DelaGarza, J; Tuteja, S; Garcia, M; Tzakis, A

Ruiz, P; Weppler, D; Tryphonopoulos, P; Nishida, S; Moon, J; Kato, T; Selvaggi, G; Levi, D; Madariaga, J; DelaGarza, J; Tuteja, S; Garcia, M; Tzakis, A.

Affiliation

Ruiz P; Department of Pathology, University of Miami School of Medicine, 1611 NW 12th Avenue, JMH Holtz Center #2101, Miami, FL 33136, USA. pruiz@med.miami.edu

Transplant Proc ; 38(6): 1750-2, 2006.

Article in En | MEDLINE | ID: mdl-16908271

Subject(s)

Antibodies, Monoclonal/adverse effects; Antibodies, Neoplasm/adverse effects; CD56 Antigen/genetics; CD59 Antigens/genetics; Gene Deletion; Hemoglobinuria, Paroxysmal/chemically induced; Alemtuzumab; Anemia, Hemolytic/etiology; Antibodies, Monoclonal, Humanized; Antigens, CD/genetics; Humans; Immunosuppressive Agents/adverse effects; Thrombosis/etiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Gene Deletion / CD59 Antigens / CD56 Antigen / Hemoglobinuria, Paroxysmal / Antibodies, Monoclonal / Antibodies, Neoplasm Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links